VANCOUVER, March 12 /CNW/ - Zecotek Medical Systems Inc. (TSX-V: ZMS;
Frankfurt: W1I.F) announced that it has demonstrated an animated image on its
2D3D Display at the official inauguration of its operational headquarters in
Singapore. The ceremony was attended by His Excellency Alan Virtue, High
Commissioner of Canada to Singapore, senior officials of the Government of
Singapore, and senior members of Singapore's business, scientific and
"I was very impressed with their new 3D Display both for its clarity and
depth," remarked the Guest of Honour His Excellency Alan Virtue, High
Commissioner of Canada to Singapore during a speech made at the inauguration.
"Zecotek serves as a thriving example to Singapore and the region of their
excellent technology, as well as the managerial and entrepreneurial talent
that Canada has to offer. Zecotek may also serve as an example to Canadian
companies of the benefits of building on Singapore's excellent infrastructure,
manufacturing base and supportive business environment as a stepping stone to
going global. We look forward to many more great things from Zecotek."
"Our 2D3D Display offers multiple viewers true volumetric visualization
and exhibits depth and parallax over a wide viewing angle unlike any other 3D
display available today," said Dr. A. F. Zerrouk, Chairman, President and CEO
of Zecotek. "The development and commercialization of our 2D3D Display
continues to be on target and our demonstrations of the technology, including
our animated image demonstration, is generating great interest."
Zecotek opened its Singapore facilities in mid-2006 to benefit from local
government cost incentives and to accelerate the commercial development of its
2D3D Display, laser, solid-state photo-detectors (MAPD) and other technologies
as a base for its laser and vanadate crystal production. The facilities
include 836 square meters (9,000 square feet) of lab, production and office
space in Singapore's Science Park II, located adjacent to the prestigious
Institute of Microelectronics and Singapore National University. Guests at the
inauguration were given a demonstration of Zecotek's 2D3D Display, lasers and
a tour of the crystal processing facilities.
"We have been delighted with the speed and efficiency of setting up in
Singapore and the quality and economy of operations," continued Dr. A. F.
Zerrouk. "We came here to benefit from government incentives and to leverage
Singapore's excellent research and development efficiencies, support
mechanisms and world class manufacturing facilities and we have not been
disappointed. We have made tremendous strides here in the past six months and
look forward to even greater successes in the immediate future."
Zecotek Medical Systems (TSX-V: ZMS; Frankfurt- W1I.F) is a bio-photonics
technology company developing high-performance crystals, photo detectors,
medical lasers, optical imaging and 3D display technologies for commercial
applications in the medical diagnostics and high-tech industry. Founded in
2003, the company has three distinct operating divisions: medical imaging,
medical lasers and 3D display and labs located in Canada, Singapore and
Russia. Zecotek commercializes its novel, patented and patent-pending
bio-photonic technologies directly and through strategic alliances and joint
ventures with multinational OEMs, distributors and other industry leaders.
This press release may contain forward-looking statements that are based
on management's expectations, estimates, projections and assumptions. These
statements are not guarantees of future performance and involve certain risks
and uncertainties, which are difficult to predict. Therefore, actual future
results and trends may differ materially from what may have been stated.
For additional information on Zecotek Medical Systems and our
technologies please see our website at www.zecotekmed.com.
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of the content of this news
release. If you would like to receive news from Zecotek in the future, please
email email@example.com and mention "ZMS News" in the subject heading or visit
the corporate website at www.zecotekmed.com.
For further information:
For further information: MICHAEL MINDER, CFO; VP Corporate Development,
T: (604) 827-5203, E: firstname.lastname@example.org